16.93
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARQT Giù?
Forum
Previsione
Arcutis Biotherapeutics Inc Azioni (ARQT) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
23.78%
81.50
|
65.85 | 71.36 | 44.76 | 30.86 |
Cost Of Revenue |
15.15%
7.492
|
8.83 | 6.905 | 5.503 | 3.464 |
Gross Profit |
29.81%
74.01
|
57.02 | 64.45 | 39.25 | 27.39 |
|
8.68%
88.62
|
81.55 | 72.09 | 78.32 | 77.47 |
Benefits Costs and Expenses |
6.35%
96.11
|
90.38 | 78.99 | 83.82 | 80.94 |
Costs And Expenses |
6.35%
96.11
|
90.38 | 78.99 | 83.82 | 80.94 |
Operating Income/Loss |
40.43%
-14.61
|
-24.53 | -7.632 | -39.07 | -50.08 |
Income/Loss From Continuing Operations Before Tax |
41.70%
-14.61
|
-25.06 | -7.632 | -39.07 | -52.33 |
Income Tax Expense/Benefit |
22.58%
0.342
|
0.279 | 0.323 | - | - |
Income/Loss From Continuing Operations After Tax |
36.61%
-15.89
|
-25.06 | -10.79 | -41.54 | -52.33 |
|
36.61%
-15.89
|
-25.06 | -10.79 | -41.54 | -52.33 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.76%
127.00
|
126.04 | 1.3299 | 124.30 | 123.48 |
Diluted Average Shares |
0.76%
127.00
|
126.04 | 1.3299 | 124.30 | 123.48 |
Basic Earnings Per Share |
35.00%
-0.13
|
-0.20 | -0.08 | -0.33 | -0.42 |
Diluted Earnings Per Share |
35.00%
-0.13
|
-0.20 | -0.08 | -0.33 | -0.42 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):